United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded May 7, 2026 · Filed May 11, 2026

On May 7, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$578.54 for US$5.5M under a trading plan, leaving 40,513 shares. Filed May 11, 2026 (Form 4).

Sold
9,500 shares
Price
US$578.54 average (US$569.70 to US$597.54)
Value
US$5.5M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 7, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 7, 2026Common StockSale500US$569.7049,513Direct
May 7, 2026Common StockSale720US$571.7948,793Direct
May 7, 2026Common StockSale876US$573.0147,917Direct
May 7, 2026Common StockSale888US$574.0147,029Direct
May 7, 2026Common StockSale1,245US$575.1545,784Direct
May 7, 2026Common StockSale751US$575.9345,033Direct
May 7, 2026Common StockSale490US$577.2744,543Direct
May 7, 2026Common StockSale510US$578.2644,033Direct
May 7, 2026Common StockSale120US$579.1143,913Direct
May 7, 2026Common StockSale509US$580.5543,404Direct
May 7, 2026Common StockSale171US$581.4743,233Direct
May 7, 2026Common StockSale440US$583.6542,793Direct
May 7, 2026Common StockSale208US$584.5742,585Direct
May 7, 2026Common StockSale512US$585.8342,073Direct
May 7, 2026Common StockSale375US$586.8441,698Direct
May 7, 2026Common StockSale545US$587.7141,153Direct
May 7, 2026Common StockSale320US$588.8640,833Direct
May 7, 2026Common StockSale160US$589.6340,673Direct
May 7, 2026Common StockSale160US$597.5440,513Direct

Source

View original at SEC

Related